The majority of patients with myasthenia gravis (MG) initially present with ocular symptoms. An unresolved question is whether there are clinical features at onset to guide clinicians to predict an individual patient's conversion risk from ocular MG (OMG) to generalized disease, or "secondary generalized MG" (SGMG), that is, a prognostic model. In light of the emerging theory that early corticosteroids may have a risk-modifying effect, the factors associated with secondary SGMG previously rep...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Ocular myasthenia gravis: controversies and updates.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record